Medical Research
(H123)
IRS Verified
DX Registered
990 on File
NATIONAL LEIOMYOSARCOMA FOUNDATION
Financial strength (30%)
66/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
- Provide annual patient education symposium series programs throughout the United States, partnering with cancer treatment research centers and research oncology. - Promote patient advocacy on issues that affect research efforts, treatment advancements, clinical trials, and drug development. - Provide vigorous LMS research funding for promising LMS research projects that have the potential to accelerate treatment options for extending survival.
Financial Overview — FY 2025
$198K
Total Revenue
$239K
Total Expenses
$412K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
98.4%
Fundraising Efficiency
N/A
Operating Reserve
20.65x
Liability-to-Asset
0.0%
Revenue Diversification
100.0%
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
98.4% | 84.6% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
1.4% | 10.0% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
20.7 mo | 11.7 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 92.2% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
9.5% | 3.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
24.5% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-20.7% | -1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $198K | $239K | $412K | 98.4% | 0 |
| 2024 | $181K | $192K | $453K | 95.7% | 0 |
| 2023 | $258K | $259K | $463K | 94.7% | 0 |
| 2022 | $265K | $135K | $465K | 97.4% | 0 |
| 2021 | $180K | $90K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.